THERAKOS CELLEX Photopheresis System
Enables single-operator management of the ECP process
The THERAKOS™ CELLEX™ Photopheresis System, from Therakos, Raritan, NJ, is a single, integrated, automated, closed system, allowing for single-operator management of the extracorporeal photopheresis (ECP) process. The system offers the same reduced risk of infection, cross-contamination, and reinfusion errors as the previous-generation UVAR™ XTS™ system while reducing treatment times (1.5 hours compared to 3 hours), minimizing extracorporeal volume, and enabling optimal fluid management. In the United States, the system is indicated for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (a rare form of Non-Hodgkin’s lymphoma) that are unresponsive to other forms of treatment.
Therakos Inc
(800) 828-6316
www.therakos.com
iScan Coreo Slide Scanner
Integrates with Virtuoso Software
The iScan Coreo, from BioImagene, Sunnyvale, Calif, is a high-throughput, high-capacity brightfield scanning system. The system provides high-speed, walkaway slides scanning, and can be fully integrated with the company’s Virtuoso software application to provide an end-to-end management, viewing, image analysis, and reporting system. iScan Coreo Live is an additional feature of the iScan Coreo, which supports telepathology without prior slide scanning. The system features a 160-slide capacity, an automated turret with four objectives (4x, 10x, 20x, and 40x), and the ability to read both 1D and 2D bar codes.
BioImagene
(408) 207-4200
[removed]www.bioimagene.com[/removed]
Immunological Fecal Occult Blood Test (IFOB)
No dietary restrictions
The Hemosure® immunological fecal occult blood test (IFOB), from Hemosure, El Monte, Calif, is an advanced screening method for colorectal cancer. The test eliminates the need for patient dietary and medication restrictions prior to testing, and it has significantly increased the chances of early detection. Easily performed in physician’s offices and labs, the test is both FDA approved and CLIA waived.
Hemosure
(626) 443-8480
www.hemosure.com
Crescendo Digital Pathology Workstation
Quantitatively assess biomarkers
BioImagene, Sunnyvale, Calif, introduces the Crescendo digital pathology workstation, which incorporates all the features of BioImagene’s Virtuoso™ application, allowing pathologists to benefit from several disease-specific Companion Algorithms™ to quantitatively assess various biomarkers. The workstation integrates silos of information, such as the laboratory information system, radiology images, gross images, online references, and differential patient information, with digital images of pathology slides to assist pathologists in making educated diagnoses. Pathologists can further use the system along with an Internet connection to collaborate with peers without the need to ship slides around.
BioImagene
(408) 207-4200
[removed]www.bioimagene.com[/removed]
ADH-5
Interprets five challenging breast diseases
The ADH-5™ Multiplex IHC stain, from Biocare Medical, Concord, Calif, provides clear differentiation of atypical ductal hyperplasia from hyperplasia of the usual type, identifying microinvasion and invasive ductal carcinoma, and distinguishing basal phenotypes in triple negatives, by simultaneously testing for five key markers of breast disease in a single procedure. ADH-5 uses one simple staining procedure and can be completed in a standard four-step IHC staining protocol. It is composed of CK5, CK14, p63, CK7, and CK18.
Biocare Medical
(800) 799-9499
www.biocare.net
Virtuoso Digital Pathology Software
End-to-end digital pathology solution
BioImagene, Sunnyvale, Calif, offers Virtuoso™, a Web-based software application enabling labs to view, manage, archive, manipulate, and analyze digital images, as well as to produce digital reports, and collaborate with other pathologists or oncologists in real time. The software features a rich menu of Companion Algorithms™ to assist pathologists in the quantitative assessment of various clinical biomarkers. Virtuoso works with the iScan family of slide scanners to provide an end-to-end digital pathology solution, from QC to sign-out. The software allows users to view images at various magnifications, track previously viewed areas, and add annotations to images. It can also reduce intra- and inter-observer variability in scoring for IHC markers.
BioImagene
(408) 207-4200
[removed]www.bioimagene.com[/removed]
Microm HM 550 Cryostat with Cold Disinfection
Produce frozen sections for oncological analysis
The Thermo Scientific Microm HM 550 cryostat with cold disinfection, from Thermo Fisher Scientific, Runcorn, UK, allows high-quality frozen sections for oncological analysis to be produced easily, rapidly, and safely. The cold disinfection system enables complete disinfection, even between samples during daily workflow. The system uses patented technology to fumigate the cold cryo-chamber while at frozen operating temperature. The fumigant is deadly to pathogens such as TB and HIV, but is completely safe to users. Cold disinfection works against aerobic bacteria and fungi in just 3 minutes, and the cryostat can be used immediately after the disinfection process is complete.
Thermo Fisher Scientific
+ 44 (0) 800 018 9396
www.thermo.com/pathology
SPOT-Light HER2 CISH
Average 2- to 5-minute read time per slide
Biocare Medical, Concord, Calif, offers the SPOT-Light® HER2 CISH kit, which provides quantitative gene-amplification results, allowing visualization of overall tumoral morphology on the same slide, using brightfield microscopy. Designed as an alternative for IHC or FISH methods, the chromogenic ISH (CISH) technology enables a fast read time average of 2 to 5 minutes per slide. Slides may be archived indefinitely for subsequent review as required.
Biocare Medical
(800) 799-9499
www.biocare.net
DxS PI3K Mutation Test Kit
Detects four somatic mutations in the PIK3CA gene
QIAGEN, Germantown, Md, offers its DxS PI3K Mutation test kit, the most recent addition to its portfolio of validated real-time PCR assays that detect mutations in biomarkers for key cancer genes. The PI3K Kit uses a combination of ARMS® (allele-specific PCR) and DxS’ own Scorpions® technology to detect four somatic mutations in the PIK3CA gene. The kit features the ability of the ARMS primers to identify and overlook the PI3K pseudogene, which allows for accurate and reliable results. A simple workflow allows the test to be run in-house on a 96-well, real-time PCR platform with time to result in less than 3 hours.
QIAGEN
(800) 426-8157
www.qiagen.com
Liquichek and Lyphochek Tumor Marker Controls
Minimum 2-year shelf life
The Liquichek™ and Lyphochek® tumor marker controls, from Bio-Rad Laboratories, Irvine, Calif, are human serum-based, third-party controls used for monitoring the precision of tumor marker testing. These trilevel multianalyte controls collectively feature cancer antigens that include: CA 15-3, CA 19-9, CA 27.29, CA 125, AFP, CEA, Ferritin, IGF-1, PAP, Prolactin, Total PSA, Free PSA, and Thyroglobulin. These controls have a minimum 2-year shelf life. Assayed values are provided for manual and automated test methods. Participation in the Unity™ Inter-laboratory Program is available.
Bio-Rad Laboratories Inc
(800) 2-BIORAD
www.bio-rad.com
CancerTYPE ID
Diagnoses metastatic cancer
bioTheranostics, San Diego, introduces the CancerTYPE ID, a 92-gene molecular cancer classification assay that assists physicians in diagnosing challenging metastatic cancer cases using real-time PCR technology. Using this gene set and its proprietary tumor database, CancerTYPE ID can distinguish and report on 54 cancer types and subtypes. Its database includes a wide range of tumor types such as breast, kidney, lung, and colon, along with rare tumors such as salivary, ovarian mucinous adenocarcinoma, cholangiocarcinoma, and various neuron-endocrine tumors. The test is compatible with formalin-fixed paraffin-embedded tissue, and is capable of handling very small samples, requiring only 300 to 500 cells for analysis.
bioTheranostics
(858) 587-5870
www.biotheranostics.com
QuickVue® iFOB
No dietary/medicine restrictions
The QuickVue® iFOB (immunochemical Fecal Occult Blood) test, from Quidel Corp, San Diego, is a diagnostic device for the qualitative detection of occult blood in stool. More sensitive than traditional guaiac-based methods, the test requires no dietary or medicine restrictions. Analytical sensitivity is 50 ng hHb/mL buffer or 50 µg hHb /g feces, specific to human hemoglobin. The specimen collection tube also doubles as convenient/sanitary dispenser for testing once the sample has been returned by the patient. The 20-test kit contains everything needed for testing; a 50-test tray pack is also available. Additional patient specimen collection and return kits are available separately in 10-test and 40-test kit sizes.
Quidel Corp
(800) 875-1517
www.quidel.com
DxS K-RAS Mutation Test Kit
Results in less than 3 hours
The DxS K-RAS Mutation Test Kit, from QIAGEN, Germantown, Md, is a highly selective and robust real-time PCR assay combining Scorpions® and ARMS® (allele-specific PCR) technologies to detect seven key mutations in the K-RAS gene. Mutations in the K-RAS oncogene are common in colorectal cancer, pancreatic cancer, lung adenocarcinoma, gall bladder cancer, bile duct cancer, and thyroid cancer. The kit can detect down to 1% of mutant in a background of wild-type genomic DNA with time to result of less than 3 hours.
QIAGEN
(800) 426-8157
www.qiagen.com
